GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro deal
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Hosted on MSN1mon
Onward wins FDA approval for ARC-EX system in spinal cord injury patients
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Boston Scientific (NYSE:BSX) Given New $115.00 Price Target at Stifel Nicolaus
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective hoisted by research analysts at Stifel Nicolaus from ...
Medical Xpress on MSN10d
Spinal cord electrical stimulation restores neural function in clinical trial
An intervention, which involves electrical stimulation of the sensory spinal nerves, can gradually reawaken functionally ...
Neurostimulation Devices Market Valuation To Surpass US$ 22.64 Billion by 2033 | Astute Analytica
Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations while engineers refine cooling techniques, improve battery resilience, and ...
Raymond James Boosts Boston Scientific (NYSE:BSX) Price Target to $122.00
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...
GEN9d
Spinal Cord Stimulation Improves Leg Strength and Walking in Adults with SMA
In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.
Future Market Insights11d
Global Spinal Cord Stimulators Market Set to Reach USD 5,441.4 Million by 2033, Driven by Technological Innovations and Clinical Advancements | FMI
Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...